Molecule that ‘Lights Up’ Cancer Accelerating Toward FDA Approval
The U.S. Food and Drug Administration has granted fast-track status to a Purdue University scientist’s optical imaging technology that may one day significantly improve outcomes for pancreatic cancer patients.
